Saturday, December 20, 2014 12:04:48 PM
LOS ANGELES, Dec. 2. 2014 /PRNewswire/ -- Migranade, Inc., the maker of MIGRANADE Migraine Relief, announced today that it has created a new division devoted to the development and marketing of a line of therapeutic homeopathic nasal sprays.
"The recent acquisition of Oasis Health Products accelerates the company's ability to formulate, test and manufacture new homeopathic nasal spray formulations," said a company spokesperson. "Our first product will be a nasal spray version of MIGRANADE Migraine Relief. This homeopathic nasal spray will allow migraine sufferers to have immediate access to the medicine while away from home."
The nasal spray is expected to hit the market in the first quarter of 2015. MIGRANADE Migraine Relief is available at http://www.migranade.com and will soon hit the major retail chains.
ABOUT MIGRANADE, INC.
Migranade, Inc. is a U.S. Pharmaceutical company with a focus on the research and development, manufacturing and marketing of medications for the treatment and prevention of migraine headache. MIGRANADE Migraine Relief is a proprietary oral effervescent medication for the treatment of migraine headaches. MIGRANADE Migraine Relief targets the actual cause of the migraine headaches vs. only treating symptoms. For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to info@migranade.com
ABOUT OASIS HEALTH PRODUCTS, INC.
Oasis Health Products, an FDA inspected, GMP facility, is one of the few manufacturers capable of producing high quality homeopathic medicines. Oasis provides formula & product development and manufacturing, advice, guidance, and contacts in areas such as sales, distribution, logistics, marketing, warehousing, etc. For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to info@migranadeinc.com.
****NOTE I WENT TO OASIS PHARMA IN EARLY SEPT. & THE BUILDNING IS WORTH A MINIMUM OF $25 MILLION DOLLARS & IS ONLY 2 YEARS OLD.
MIGRANADE WILL EITHER
1. BUYOUT EMESYL PRODUCT,
2. DO A REVERSE MERGER INTO ITNS SO THEY CAN BECOME A PUBLIC TRADING COMPANY.
3. BUYOUT ITNS TOTALLY
IN ANY EVENT SOMETHING HUGE IS GOING ON HERE BETWEEN ITNS & MIGRANADE.
ONLY PATIENCE & TIME WILL UNVAIL THE FACTS.
BEST PLAY IN PENNYLAND FO0R THE RISK/REWARD OF A SMALL INVESTMENT THAT I KNOW OF!!!!!
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM